Creating communities of compassionate care to transform difficult psychedelic experiences into opportunities for learning & growth

“Every year, tens of millions of people use psychedelics to enhance their life experiences. Sometimes, especially in public settings, psychedelic experiences can be difficult or overwhelming. As a healthcare provider, I understand people are going to use drugs regardless of legal status. All we want to do is help people. Harm reduction is a vital tool in reducing negative outcomes with drug use and that’s why I’m offering a matching donation to the Zendo Project.”    -- Community Physician & Donor

Your gift will support psychedelic harm reduction initiatives at the Multidisciplinary Association for Psychedelic Studies (MAPS) including the Zendo Project.

For ten years, MAPS' Zendo Project has been entirely funded by donors like you to provide compassionate support for people undergoing difficult psychedelic experiences. The Zendo Project facilitates psychedelic harm reduction by training volunteers and professionals like first responders to provide education, resources, and peer support services, particularly at large events. This year, the Zendo Project will return to Burning Man to provide peer support services after a two-year hiatus due to COVID-19.  

Donors like you have helped prevent and transform thousands of difficult psychedelic experiences through educating and training volunteers. Peer support services help reduce the number of psychedelic-related hospitalizations and arrests by providing non-judgmental and trauma-informed support to those undergoing difficult experiences.  

You can learn more about our psychedelic harm reduction initiatives at maps.org and zendoproject.org.

Show love, spread love 

Zendo Project: Psychedelic Peer Support

The Multidisciplinary Association for Psychedelic Studies supports psychedelic and cannabis research, education and policy reform.

Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a visionary 501(c)(3) non-profit organization ushering the safe and ethical use of psychedelics as tools for healing and growth on individual, familial, societal, and planetary levels.

MAPS’ top priority is ethically introducing global access to MDMA-assisted therapy as a treatment for posttraumatic stress disorder (PTSD) through regulatory approvals and training certification for therapy providers, as well as public education, policy reform, and building community support networks.

How Your Donation Will Help

While the MDMA drug development program is the main priority of MAPS, the organization's programs include research into other psychedelic compounds and provide critical resources for researchers around the world interested in studying psychedelics. These resources include assistance with protocol development and regulatory guidance, in addition to providing study drug and training for investigators. As part of its commitment to open science and open praxis, MAPS publishes its research protocols, treatment manual for MDMA-assisted therapy for PTSD, published articles, and investigator's brochure on its website for free download, and actively collaborates with third-party researchers and institutions. Researchers and institutions around the world are building on the body of research that MAPS has produced.

MAPS operates a global network of intersectional education and research programs focused on the careful study of the risks and benefits of psychedelics. The education programs include: harm reduction and peer support through the Zendo Project; policy and advocacy efforts focused on community organizing and reducing barriers to research; a conflict resolution initiative for peace-building; and an active fiscal sponsorship program for fledgling mission-aligned organizations. MAPS also produces myriad educational materials, training workshops, and conferences, both physical and virtual. MAPS builds its global community of support through: outreach at events worldwide; a robust social media presence; and interviews and publications in various global media outlets. All of this work is supported by MAPS’ general operating fund. 

MAPS aims to transcend geopolitical and social boundaries and intentionally cultivates interactions with thought leaders in a broad range of interest areas and outlets that demonstrate the broad applications of the healing potential of psychedelics, and to proactively build trust and common ground with those most likely to have resistance to psychedelics.  

A Tipping Point for Psychedelic Medicine

MDMA-assisted therapy is poised to be a true breakthrough for psychedelic medicine and is the first psychedelic therapy to enter a Phase 3 clinical trial. This trial recently cleared a critical interim evaluation, with analysis confirming a 90% or greater likelihood that the final results will show significant effectiveness in treating PTSD. Achieving FDA approval for this treatment could be the tipping point to shifting psychedelics into the medical mainstream. This shift has the potential to unlock previously unavailable resources for the investigation of psychedelic-assisted treatments applied to our most critical mental health challenges: trauma, depression, addiction, anxiety, and more.

When administered in a clinical setting with trained therapy providers, MDMA has proven to be a powerful adjunct to therapy, which assists individuals in processing traumatic experiences in a deep and profound manner, leading to the alleviation of suffering. Clinical research indicates that MDMA may catalyze therapeutic processing by allowing participants to stay emotionally engaged when revisiting traumatic experiences, without feeling overwhelmed by anxiety or other painful emotions.

FDA approval of MDMA-assisted therapy for PTSD could help millions of people who are suffering from trauma. A long-term follow-up study published in June 2020 demonstrated that 67% of the study volunteers (N=91) who had PTSD for an average duration of 17.8 years were still in remission and no longer qualified for a PTSD diagnosis at least 12-months following the completion of their treatment. 

While MAPS is the engine that powers this research, passionate supporters are the fuel that feeds our fire. We are inspired to press on towards the finish line of this 35-year marathon.

If you have any questions, please email us at giving@maps.org.

MAPS

EJI is committed to ending mass incarceration in the US and challenging racial and economic injustice.

Founded in 1989 by Bryan Stevenson, a widely acclaimed public interest lawyer and bestselling author of Just Mercy, EJI is a private, 501(c)(3) nonprofit organization that provides legal representation to people who have been illegally convicted, unfairly sentenced, or abused in state jails and prisons. We challenge the death penalty and excessive punishment and we provide re-entry assistance to formerly incarcerated people.

EJI works with communities that have been marginalized by poverty and discouraged by unequal treatment. We are committed to changing the narrative about race in America. EJI produces groundbreaking reports, an award-winning wall calendar, and short films that explore our nation’s history of racial injustice, and we recently launched an ambitious national effort to create new spaces, markers, and memorials that address the legacy of slavery, lynching, and racial segregation, which shapes many issues today.

EJI provides research and recommendations to assist advocates and policymakers in the critically important work of criminal justice reform. We publish reports, discussion guides, and other educational materials, and our staff conduct educational tours and presentations for thousands of students, teachers, faith leaders, professional associations, community groups, and international visitors every year.

Equal Justice Initiative

Developing the roadmap for a sustainable, secure, and just global protein supply 🧫🌱


Check out what your support makes possible at gfi.org/your-impact. 

The Good Food Institute (GFI) is a global network of nonprofit organizations developing the roadmap for a sustainable, secure, and just protein supply. Industry alone will not meet this challenge at the scale or speed we need. GFI is accelerating the transformation of the food system by identifying solutions and mobilizing resources to make alternative proteins the default way meat is made.

GFI is a network of nonprofits around the world strategically based in the most critical economies for alternative protein advancement. In Asia, Europe, Brazil, India, Israel, and the U.S., GFI’s teams are mobilizing the international community to use markets and technology to replace harmful practices with ones that are better for the climate and biodiversity, for food security, and for global health.

GFI’s Focus
As a nonprofit, GFI is uniquely positioned to accelerate the transition to alternative proteins by focusing on three programmatic priorities:

-Cultivating a strong scientific ecosystem | GFI’s science and technology teams map out the most neglected areas that will allow alternative proteins to compete on taste and price. GFI meets these challenges by developing open-access research and resources, educating and connecting the next generation of scientists and entrepreneurs, and funding research that benefits alternative protein development across the sector. 

-Influencing policy and securing government funding | GFI’s policy teams ensure that alternative proteins are a part of the policy discussion around climate change mitigation and global health. In every region where GFI has a presence, teams advocate for government funding and incentives to transition to alternative proteins and are paving the way for the approval of novel proteins such as cultivated meat.

-Ensuring industry prioritizes alternative proteins | GFI’s corporate teams are creating a transformation of our global meat supply. GFI works to replicate past market transformations by showing companies of all sizes, from startups to multinational corporations, how alternatives to animal products can be profitable while meeting environmental, social, and governance goals.

Reimagining meat
The very real threats of climate change, global food insecurity, antibiotic resistance, and pandemics require us to imagine a different future of food. Alternative proteins are the solution that will securely and sustainably feed the world.

GFI’s global community of scientists, policy experts, and corporate specialists are creating a world where alternative proteins are no longer alternative.



The Good Food Institute

K42v2rPnyXTvEMlOPwVL8Cac/MSSUeXlt4aqkWPQoso=

JZdS6B3cD+UO3QRVzk7sZ8JsCjgig2xN8nP4mpEn31M=

Thank you to MAPS and Zendo for bringing this very important service to the psychedelic community <3